Video Experimental Relacionado
Updated: Aug 19, 2026
12:02
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
La preeclampsia es también llamada preeclampsia
1Department of Obstetrics and Gynaecology, St James's University Hospital, Leeds, UK. j.j.walker@leeds.ac.uk
Lancet (London, England)
|November 10, 2000
Resumen
La preeclampsia es una complicación grave del embarazo que afecta a madres y bebés, pero se resuelve después del parto. Los avances en el manejo incluyen terapia antihipertensiva y sulfato de magnesio.
Área de la Ciencia:
- Obstetricia y Ginecología.
- La medicina materno-fetal es una de ellas.
- Salud perinatal La salud perinatal.
Sus antecedentes:
- La preeclampsia plantea riesgos significativos para la morbilidad y mortalidad materna e infantil.
- A pesar de la disminución de la mortalidad en los países desarrollados, sigue siendo una de las principales causas de muerte relacionada con el embarazo.
- La condición se origina en un desencadenante placentario, lo que lleva a una respuesta sistémica materna.
Objetivo del estudio:
- Revisar la fisiopatología y el manejo de la preeclampsia.
- Para resaltar los avances en el tratamiento de este complejo trastorno del embarazo.
Principales métodos:
- Revisión de la literatura sobre la fisiopatología de la preeclampsia.
- Análisis de las estrategias de gestión actuales y su efectividad.
Principales resultados:
- La presentación de la preeclampsia es variable debido a respuestas sistémicas inconsistentes.
- Múltiples sistemas de órganos pueden verse afectados por el trastorno.
- El manejo efectivo incluye terapia antihipertensiva, sulfato de magnesio y restricción de fluidos.
Conclusiones:
- Comprender el proceso de la enfermedad de la preeclampsia ha mejorado la atención al paciente.
- El manejo oportuno y apropiado puede mitigar los resultados graves.
- La investigación continua es vital para reducir aún más el impacto de la preeclampsia.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...